Features
Antisepsis for Intravitreal Injections
Povidone-iodine can decrease risk of endophthalmitis.
By Allison B. Hansen, BS, Kamal Kishore, MD, FASRS
Retina Clinic Considerations in the Era of Treatment for Advanced Dry AMD
Practices can make a number of adjustments to prepare for a new therapy.
By Yingna Liu, MD, Roger A. Goldberg, MD, MBA
Current Status of Subretinal Delivery Devices
Options are being developed for gene therapy, drug delivery, and submacular hemorrhage displacement.
By Prethy Rao, MD, MPH, Edward Wood, MD, Tamer Mahmoud, MD, PhD
Connecting With Patients About Geographic Atrophy
Outreach and communication will be critical with new therapies.
By David S. Liao, MD, David S. Boyer, MD
Overcoming Retina Clinical Trial Challenges With Tailored Solutions
Several companies offer services for sites that can streamline the clinical trial process.
By Marcus J. Solomon, MD
Departments
UPFRONT: The Beginning of Geographic Atrophy Treatment
By Peter K. Kaiser, MD
CODING Q&A: Modifier 25 for Same-day Exam and Procedure
Bill separately only if unrelated to the procedure.
By Brandy H. Sperry, COMT, COE, CPC, CPMA, Suzanne L. Corcoran, COE
UVEITIS CORNER: Interpreting Optical Coherence Tomography Findings of Retinal Whitening
The finding occurs in infectious, inflammatory, and ischemic retinal disease.
By Jacob Fondriest, MD, Veena Raiji, MD
RETINA CONVERSATIONS: A Conversation About Optoretinography
Ravi S. Jonnal, PhD, and Glenn Yiu, MD, PhD, describe new imaging innovations that could more easily assess retinal function at the photoreceptor level.
By Jennifer Ford, senior managing editor
NEW PRODUCT APPLICATIONS: RetinAI Discovery Core Platform Accelerates Research
Clinicians can use this resource to enrich and analyze OCT images instantaneously.
By Karen Appold, contributing writer
News
SUBSPECIALTY NEWS: Early anti-VEGF for DR shows no benefit, developments in gene therapy, research on IRD, and more.
By Rochelle Nataloni, contributing writer